Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport

Human Molecular Genetics

Volumn 11, Issue 23, 2002, Pages 2837-2844

  Brownlees, Janet ^a   Ackerley, Steven ^a   Grierson, Andrew J ^a,b   Jacobsen, Nick J O ^a   Shea, Kerry ^a   Anderton, Brian H ^a   Leigh, P Nigel ^a   Shaw, Christopher E ^a   Miller, Christopher C J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; NEUROFILAMENT PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL CULTURE; CELL METABOLISM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETIC NEUROPATHY; DIFFUSE LEWY BODY DISEASE; GENE MUTATION; GENETIC DISORDER; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN CELL; INTERMEDIATE FILAMENT; MAMMAL CELL; MITOCHONDRION; NERVE CELL; NERVE FIBER TRANSPORT; NEUROFILAMENT; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN ASSEMBLY;

MAMMALIA;

EID: 0036849511     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.23.2837     Document Type: Article

References (50)

1. Reilly, M.M. (2000) Classification of the hereditary motor and sensory neuropathies. Curr. Opin. Neurol., 13, 561-564.
2. Young, P. and Suter, U. (2001) Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease. Brain Res. Rev., 36, 213-221.
3. Bennett, C.L. and Chance, P.F. (2001) Molecular pathogenesis of hereditary motor, sensory and autonomic neuropathies. Curr. Opin. Neurol., 14, 621-627.
4. Baxter, R.V., Othmane, K.B., Rochelle, J.M., Stajich, J.E., Hulette, C., Dew-Knight, S., Hentati, F, Hamida, M.B., Bel, S., Stenger, J.E. et al. (2002) Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease 4A/8q2l. Nat. Genet., 30, 21-22.
5. Cuesta, A., Pedrola, L., Sevilla, T., Garcia-Planells, J., Chumillas, M.J., Mayordomo, F., LeGuern, E., Marin, I., Vilchez, J.J. and Palau, F. (2002) The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in Charcot-Marie-Tooth type 4A disease. Nat. Genet., 30, 22-25.
6. Boerkoel, C.F., Takashima, H., Garcia, C.A., Olney, R.K., Johnson, J., Berry, K., Russo, P, Kennedy, S., Teebi, A.S., Scavina, M. et al. (2002) Charcot-Marie-Tooth disease and related neuropathies: Mutation distribution and genotype-phenotype correlation. Ann. Neurol., 51, 190-201.
7. Mersiyanova, I.V, Perepelov, A.V, Polyakov, A.V., Sitnikov, VE., Dadali, E.L., Oparin, R.B., Petrin, A.N. and Evgrafov, O.V. (2000) A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet., 67, 37-46.
8. De Jonghe, P., Mersivanova, I., Nelis, E., Del Favero, J., Martin, J.J., Van Broeckhoven, C., Evgrafov, O.C. and Timmerman, V. (2001) Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann. Neurol., 49, 245-249.
9. Lee, M.K. and Cleveland, D.W. (1996) Neuronal intermediate filaments. Annu. Rev. Neurosci., 19, 187-217.
10. Grant, P. and Pant, H.C. (2000) Neurofilament protein synthesis and phosphorylation. J. Neurocytol., 29, 843-872.
11. Gill, S.R., Wong, P.C., Monteiro, M.J. and Cleveland, D.C. (1990) Assembly properties of dominant and recessive mutations in the small mouse neurofilament (NF-L) subunit. J. Cell Biol., 111, 2005-2019.
12. Ching, G.Y. and Liem, R.K.H. (1999) Analysis of the roles of the head domains of type IV rat neuronal intermediate filament proteins in filament assembly using domain-swapped chimeric proteins. J. Cell Sci., 112, 2233-2240.
13. Nakagawa, T., Chen, J., Zhang, Z., Kanai, Y. and Hirokawa, N. (1995) Two distinct functions of the carboxyl-terminal tail domain of NF-M upon neurofilament assembly: cross-bridge formation and the longitudinal elongation of filaments. J. Cell Biol., 129, 411-429.
14. Chen, J.G., Nakata, T., Zhang, Z.Z. and Hirokawa, N. (2000) The C-terminal tail domain of neurofilament protein-H (NF-H) forms the crossbridges and regulates neurofilament bundle formation. J. Cell Sci., 113, 3861-3869.
15. Ching, G.Y. and Liem, R.K. (1993) Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J. Cell Biol., 122, 1323-1335.
16. Lee, M.K., Xu, Z., Wong, P.C. and Cleveland, D.W. (1993) Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol., 122, 1337-1350.
17. Ackerley, S., Grierson, A.J., Brownlees, J., Thornhill, P, Anderton, B H., Leigh, P.N., Shaw, C.E. and Miller, C.C.J. (2000) Glutamate slows axonal transport of neurofilaments in transfected neurons. J. Cell Biol., 150, 165-175.
18. Wang, L. and Brown, A. (2001) Rapid intermittent movement of axonal neurofilaments observed by fluorescence photobleaching. Mol. Biol. Cell, 12, 3257-3267.
19. Carter, J., Gragerov, A., Konvicka, K., Elder, G., Weinstein, H. and Lazzarini, R.A. (1998) Neurofilament (NF) assembly; divergent characteristics of human and rodent NF-L subunits. J. Biol. Chem., 273, 5101-5108.
20. Yabe, J.T, Pimenta, A. and Shea, T.B. (1999) Kinesin-mediated transport of neurofilament protein oligomers in growing axons. J. Cell Sci., 112, 3799-3814.
21. Wang, L., Ho, C.-I., Sun, D., Liem, R.K.H. and Brown, A. (2000) Rapid movement of axonal neurofilaments interrupted by prolonged pauses. Nat. Cell Biol., 2, 137-141.
22. Roy, S., Coffee, P, Smith, G., Liem, R.K.H., Brady, S.T. and Black, M.M. (2000) Neurofilaments are transported rapidly but intermittently in axons: Implications for slow axonal transport. J. Neurosci., 20, 6849-6861.
23. Brown, A. (2000) Slow axonal transport: stop and go traffic in the axon. Nat. Rev. Mol. Cell Biol., 1, 153-156.
24. Shea, T.B. and Flanagan, L.A. (2001) Kinesin, dynein and neurofilament transport. Trends Neurosci., 24, 644-648.
25. Shah, J.V and Cleveland, D.W. (2002) Slow axonal transport: fast motors in the slow lane. Curr. Opin. Cell Biol., 14, 58-62.
26. Miller, C.C.J., Ackerley, S., Brownlees, J., Grierson, A.J., Jacobsen, N.J.O. and Thornhill, P. (2002) Axonal transport of neurofilaments in normal and disease states. Cell. Mol. Life Sci., 59, 323-330.
27. Stamer, K., Vogel, R., Thies, E., Mandelkow, E. and Mandelkow, E.-M. (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol., 156, 1051-1063.
28. Rizzuto, R., Brini, M., Pizzo, P., Murgia, M. and Pozzan, T. (1995) Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cells. Curr. Biol., 5, 635-642.
29. Figlewicz, D.A., Krizus, A., Martinoli, M.G., Meininger, V, Dib, M., Rouleau, G.A. and Julien, J.-P (1994) Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet., 3, 1757-1761.
30. Tomkins, J., Usher, P, Slade, J.Y., Ince, PG., Curtis, A., Bushby, K. and Shaw, P.J. (1998) Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport, 9, 3967-3970.
31. Al-Chalabi, A., Anderson, P.M., Nilsson, R, Chioza, B., Andersson, J.L., Russ, C.R., Shaw, C.E., Powell, J.F. and Leigh, P.N. (1999) Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum. Mol. Genet, 8, 157-164.
32. Lavedan, C., Buchholtz, S., Nussbaum, R.L., Albin, R.L and Polymeropoulos, M.H. (2002) A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration. Neurosci. Lett., 322, 57-61.
33. Julien, J.P. (1999) Neurofilament functions in health and disease. Curr. Opin. Neurobiol., 9, 554-560.
34. Cleveland, D.W. and Rothstein, J.D. (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci., 2, 806-819.
35. Cote, F., Collard, J.-F. and Julien, J.-P. (1993) Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell, 73, 35-46.
36. Xu, Z., Cork, L.C., Griffin, J.W and Cleveland, D.W (1993) Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell, 73, 23-33.
37. Lee, M.K., Marszalek, J.R. and Clevelana D.W. (1994) A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease. Neuron, 13, 975-988.
38. Beaulieu, J.M., Nguyen, M.D. and Julien, J.P. (1999) Late onset death of motor neurons in mice overexpressing wild-type peripherin. J. Cell Biol., 147, 531-544.
39. Couillard-Després, S., Zhu, Q.Z., Wong, P.C., Price, D.L., Cleveland, D.W. and Julien, J.P. (1998) Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc. Natl Acad. Sci. USA, 95, 9626-9630.
40. Williamson, T.L., Bruijn, L.I., Zhu, Q.Z., Anderson, K.L., Anderson, S.D., Julien, J.P. and Cleveland, D.W (1998) Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant Proc. Natl Acad. Sci. USA, 95, 9631-9636.
41. Kong J.M. and Xu, Z.S. (2000) Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis. Neurosci. Lett., 281, 72-74.
42. Nguyen, M.D., Larivière, R.C. and Julien, J.P. (2001) Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron, 30, 135-147.
43. Robertson, J., Beaulieu, J.M., Doroudchi, M.M., Durham, H.D., Julien, J.P. and Mushynski, WE. (2001) Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine TNFα J. Cell Biol., 155, 217-226.
44. Collard, J.-E, Cote, F. and Julien, J.-P. (1995) Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature, 375, 61-64.
45. Zhang, P., Tu, P.-h., Abtahian, F., Trojanowski, J.Q. and Lee, V.M.-Y. (1997) Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell. Biol., 139, 1307-1315.
46. Williamson, T.L. and Cleveland, D.W (1999) Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci., 2, 50-56.
47. Zhao, C., Takita, J., Tanaka, Y., Setou, M., Nakagawa, T., Takeda, S., Yang, H.W., Terada, S., Nakata, T., Takei, Y. et al. (2001) Charcot-Marie-Tooth disease type 2a caused by mutation in a microtubule motor kiflbβ. Cell, 105, 587-597.
48. 55 mutants in transfected mammalian cells. J. Neurochem., 66, 1306-1311.
49. Nikolic, M., Dudek, H., Kwon, Y.T., Ramos, Y.F.M. and Tsai, L.H. (1996) The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev., 10, 816-825.
50. Xia, Z.G., Dudek, H., Miranti, C.K. and Greenberg, M.E. (1996) Calcium influx via the NMDA receptor induces immediate-early gene-transcription by a MAP kinase/ERK-dependent mechanism. J. Neurosci., 16, 5425-5436.